NCT06213038View on ClinicalTrials.gov

A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Neovascular Age-related Macular Degeneration
Interventions
GENETIC

SKG0106

SKG0106 is a recombinant adeno-associated virus (AAV) vector-based in vivo gene therapeutic product

Trial Locations (3)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

Eye & ENT Hospital of Fudan University, Shanghai

RECRUITING

Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of MedicineXin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Youxin Chen

OTHER